The largest database of trusted experimental protocols

Affymetrix human exon 1.0 st array

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Affymetrix Human Exon 1.0 ST Array is a microarray platform designed for the analysis of gene expression and alternative splicing. It provides comprehensive coverage of the human transcriptome, with probes targeting over 1 million known and predicted exons. The array enables researchers to investigate the expression of individual exons, as well as alternative splicing events, across the entire human genome.

Automatically generated - may contain errors

18 protocols using affymetrix human exon 1.0 st array

1

Analyzing Gene Expression Profiles in Oral Carcinogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The raw data of GSE85195 [10 (link)] and GSE25099 [11 (link)] were downloaded from Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/) and processed using R software (4.0.5). Agilent's microarray sequencing chip was used in GSE85195; the sample type was Homo sapiens tissue samples; and the sequencing platform was the GPL6480 (Agilent-014850 Whole Human Genome Microarray 4 × 44 K G4112 F). The samples included 1 normal tissue, 15 OLK tissues, and 34 OSCC tissues. Affymetrix's microarray sequencing chip was used in GSE25099; the sample type was Homo sapiens tissue samples; and the sequencing platform was the GPL5175 (Affymetrix Human Exon 1.0 ST Array). The samples included 22 normal tissues and 57 OSCC tissues. The detailed information is shown in Table 1. The normalizeBetweenArrays function of the limma package [12 (link)] and the RMA method of the affy [13 (link)] package was used to perform data standardization, normalization, and gene annotation, remove probes without annotation information, take the average expression when the same probe appears multiple times, and take the common gene combined data in the two datasets. The ComBat method of the sva package [14 (link)] was used to remove batch effects between multiple datasets to obtain a gene expression matrix.
+ Open protocol
+ Expand
2

External Validation of Differentially Expressed Genes in Colorectal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
External validation of the predictive value of those differentially expressed genes found in our series to discriminate between primary tumors and non-tumoral colorectal tissues, was performed in a group of previously reported metastatic sCRC patients (n = 47) from whom GEP array data files (Affymetrix Human Genome U133 Plus 2.0 Array) are publicly available at the GEO database (accession number GSE21510) [50 (link)]. Additionally, to discriminate between liver metastases and non-tumoral colorectal tissues, we performed an external validation in another group of previously reported metastatic sCRC patients (n = 24) from whom GEP array data files (Affymetrix Human Exon 1.0 ST Array) are also publicly available at the GEO database (accession number GSE35834) [36 (link)].
Downloaded data CEL files were normalized using the RMA algorithm and overlapping probe sets were defined on the basis of probe specificity, using the GATExplorer server [59 (link)]. Probe sets with the best specificity to the interrogated genes were selected, and the expression signals detected for each gene for each probe set were further analyzed using the column metric preserving biplot assay [60 (link)] implemented in the SIMFIT statistical software (http://www.simfit.org.uk/).
+ Open protocol
+ Expand
3

Parkinson's Disease Blood Transcriptome Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
We applied “Parkinson’s disease”, “human beings”, “peripheral blood”, “expression profiling by array” as key words and ensured that each group has more than 10 subjects, the gene expression matrix of GSE18838 dataset [19 (link)] was obtained from the NCBI Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/geo/) (Accessed: 1 May 2022). The GSE18838 dataset included 17 PD and 11 healthy control (HC) whole blood samples, which was performed on GPL5175 platform ([HuEx-1_0-st] Affymetrix Human Exon 1.0 ST Array [transcript (gene) version]). The clinical characteristics of participates in GSE18838 are detailed in (Additional file 1: Table S1).
FerrDb (http://www.zhounan.org/ferrdb/) (Accessed: 2 May 2022) collected 259 ferroptosis-related genes (FRGs) including driver, suppressor and marker [20 ]. The confidence level of recorded genes involved in ferroptosis was assigned to 4 degrees including validated, screened, predicted and deduced.
+ Open protocol
+ Expand
4

FRZB Expression in Comprehensive HNSCC Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sequence data and the relative clinical information was collected from The
Cancer Genome Atlas (TCGA). As the largest cancer genetic information database
for large-scale genome sequencing and other data like proteomic, epigenetic,
transcriptomic, and genomic, TCGA database includes 33 types of cancer. As
Supplementary Table
S1
shows, we found the expression of FRZB
and complete clinical data for 499 HNSCC patients. TIMER2 webserver was employed
for analyzing FRZB expression of pan-cancer (11 (link)). In order to determine the expression of FRZB in HNSCC patients,
the datasets GSE30784, GSE25099, and GSE37991 were collected from the Gene
Expression Omnibus (GEO). GSE30784 includes 167 oral squamous cell carcinoma
(OSCC) samples and 45 adjacent normal samples from the GPL570 platform
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array. The GPL5175
platform [HuEx-1_0-st] Affymetrix Human Exon 1.0 ST Array was used to obtain
GSE25099, which includes 22 adjacent normal samples and 57 OSCC samples.
GSE37991 was from GPL6883 Illumina HumanRef-8 v3.0 expression bead chip, and
includes 40 OSCC and 40 adjacent normal samples. FRZB expression was analyzed in
different clinical subgroups comprehensively by using UALCAN webserver (12 (link)).
+ Open protocol
+ Expand
5

Comprehensive Meta-Analysis of Sjögren's Syndrome Transcriptomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The gene expression profiles of the datasets GSE84844, GSE66795, GSE140161, GSE48378, and GSE23117 were acquired from the GEO database. GSE84844 included data for whole blood samples from 30 patients with pSS and 30 healthy volunteers and was analyzed using the GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array. GSE66795 contained data for 131 whole blood samples from patients with fully phenotyped pSS and 29 healthy controls and was analyzed using the GPL10558 Illumina HumanHT-12 v4.0 expression beadchip. GSE140161 contained data for 351 whole blood samples from 30 patients with pSS and was analyzed using the GPL23159 platform [Clariom_S_Human] Affymetrix Clariom S Assay, human (includes Pico Assay). GSE48378 contained data for peripheral blood mononuclear cells from 11 patients with pSS and 16 healthy controls and was analyzed using the GPL5175 [HuEx-1_0-st] Affymetrix Human Exon 1.0 ST Array [transcript (gene) version] platform. GSE23117 contained data for minor salivary gland samples from 10 patients with SS and 5 controls and was analyzed using the GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array.
+ Open protocol
+ Expand
6

Breast Cancer Gene Expression Profiles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression profiles for the 3 genes, GSE89116, GSE109169, and GSE1390383, were downloaded from the GEO database (http://www.ncbi.nlm.nih.gov/geo/), a public functional genomics data repository that supports MIAME-compliant data submissions. In the database, tools are provided to help users query and download experimental and curated gene expression profiles. GSE89116 was sequenced on the GPL6947 platform(Illumina HumanHT-12 V3.0 expression BeadChip) from 9 breast cancer and 24 normal breast tissues, GSE109169 was generated on the GPL5175 platform, (HuEx-1_0-st) Affymetrix Human Exon 1.0 ST Array [transcript (gene) version] from 25 breast cancer and 25 normal breast tissues, and GSE139038 was sequenced on the GPL27630 platform [Print_1437 (Block_Column_Row IDs)] from 41 breast cancer and 18 normal breast tissues.13 (link)
+ Open protocol
+ Expand
7

Transcript Characterization by Alternative Splicing Events

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transcripts characterized by alternative splicing events at their 3′ end were detected by R scripting using Bioconductor 2.12 packages GenomicRanges, TxDb.Hsapiens.UCSC.hg19.knownGene and HuExExonProbesetLocation (www.bioconductor.org). Transcripts were extracted from TxDb.Hsapiens.UCSC.hg19.knownGene (80922 transcripts). After removal of transcripts lacking a link to Entrez Gene Identifier (20 (link)), 71 350 transcripts (26 5661 exons), associated to 22 932 EG, were left for further analysis. Subsequently, we selected all genes associated to the presence of alternative splicing even at the 3′ end (12 839 genes, 58 451 transcripts, 26 608 exons involved in ALE). Affymetrix Human Exon 1.0 ST Array (HuEx-1_0-st) exon-level probe sets chromosomal locations were extracted from HuExExonProbesetLocation (21 ). Only exon-level probesets associated to the Affymetrix core annotation were considered (284805 exon-level probesets). These exon-level probesets mapped on 12839 genes (59 986 UCSC transcripts, 230 112 exons). Out of the 230 112 exons 22 983 were associated to ALE. Alternatively spliced exon-level probesets were retrieved by Lenzken et al. (16 (link)). Four hyndred six exon-level probesets mapping on 418 exons were associated to 262 genes (1191 UCSC transcripts, 4844 exons). Within the 418 exons 89 exons (78 UCSC genes) were involved in ALE.
+ Open protocol
+ Expand
8

Stem Cell Transcriptional Profiling Meta-analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used data from public databases Gene Expression Omnibus (GEO) [53 , 54 ] and ArrayExpress [55 ]. Each sample belongs to one of the following classes: embryonic stem cell (ESC), induced pluripotent stem cell (iPSC), embryonic progenitor cell (EPC), adult stem cell (ASC) and adult cell (AC). Samples in this study were obtained from the following microarray platforms: Illumina HumanHT-12 V4.0 (GPL10558), Illumina HumanHT-12 V3.0 (GPL6947), Affymetrix HT Human Genome U133A Array (GPL3921), Affymetrix GeneChip Human Genome U133 Array Set HG-U133A (GPL4557), Affymetrix Human Exon 1.0 ST Array (GPL5188), Affymetrix Human Genome U133 Plus 2.0 Array (GPL570), Affymetrix Human Genome U133A 2.0 Array (GPL571), Affymetrix Human Gene 1.0 ST Array (GPL6244), Affymetrix Human Genome U133A Array (GPL96), Affymetrix Human Genome U133 Plus 2.0 Array (GPL11670). The final number of samples used for training and validation were grouped by platform vendor and cell type and shown in Supplementary Table 4.
+ Open protocol
+ Expand
9

Plasma Cell Gene Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gene expression datasets GSE39754, GSE6477 and GSE24080 were obtained based on NCBI-GEO (http://www.ncbi.nlm.nih.gov/geo). GSE39754 data were acquired with GPL5175 platform ([HuEx-1_0-st] Affymetrix Human Exon 1.0 ST Array [transcript (gene) version]), which involved purified plasma cell samples obtained in 170 MM cases together with 6 normal subjects. GSE6477 data were obtained from the GPL96 platform ([HG-U133a] Affymetrix Human Genome U133A Array), which included purified plasma cell samples collected in 103 cases as well as 15 normal subjects. GSE24080 data were gathered from the GPL570 ([HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array), which contained bone marrow plasma cell gene expression profiles for survival analysis and GSEA.
+ Open protocol
+ Expand
10

BRD4 Expression in Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression data of prostate cancer biopsies were obtained as quantile-normalized values from the publication by Brase et al.24 (link) GEO database (NCBI, GEO, GSE29079). For the determination of BRD4 expression levels, we used the core probe set of the Affymetrix human exon 1.0 ST array (Affymetrix, Santa Clara, CA, USA). The BRD4 core probes are located at the very C-terminus of the long BRD4 isoform.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!